U.S. Food And Drug Administration

Groundbreaking: FDA Reviews MDMA Therapy For PTSD, Accepts New Drug Application
Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More
Cannabis Research Company Submits FDA Responses For Gel Capsule Approval
Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More
Cannabis Research Company Submits FDA Responses For Gel Capsule Approval
EXCLUSIVE: Curaleaf Chairman Predicts DEA's Future Steps On Cannabis Rescheduling
Ripple Effect: How Marijuana Legalization Impacts Global Drug Cartels, Senators' Letter Reveals

U.S. Food And Drug Administration Recent News

Why Changing Marijuana's DEA Categorization Could Be 'The Most Consequential Action Out Of DC'
In a recent interview at the Benzinga Cannabis Capital Conference in Miami, Kris Krane, cannabis industry consultant and director of cannabis development for KCSA Strategic Communications, stressed the crucial focus on the presidential administration this year.
Healthcare Advocates United: A Push For Congress To Recognize CBD As Dietary Supplements
In the realm of healthcare advocacy, two organizations have joined forces to battle a shared adversary: unregulated CBD.
'War on Vapes' Intensifies: FDA Seizes Disposable Vapes, NYC Files Lawsuit, UK Calls For Ban On Single-Use Vapes
"We're not going to stand by as bad actors are profiting off the sale of illegal products that are addicting our nation's youth," declared Brian King, director of the FDA's Tobacco Center, signaling a new era of regulatory action against the vapi
Oreo Copycat 'Stoneos' Told To Cease And Desist As FTC Cracks Down On THC Edibles
To protect children from inadvertently consuming cannabis-infused snacks, the U.S. Federal Trade Commission (FTC) and Food and Drug Administration (FDA) sent cease and desist letters to six marijuana companies.
Biden Cites Federal Cannabis Pardons And Possible Policy Reforms In His Juneteenth Proclamation
President Joe Biden's Juneteenth proclamation signaled a potential shift in cannabis policy.
Federal Cannabis Scheduling Decision Expected 'This Year,' Says Biden's Health Secretary
The U.S.
Rhode Island Advances Psilocybin Reform With Bill To Legalize Therapeutic Access And Cultivation
Rhode Island is making progress in the area of psychedelics reform as lawmakers approved a bill that could legalize psilocybin mushrooms.
Pennsylvania Fights Drug Overdose Crisis With Naloxone Campaign Extension
In 2022, the Food and Drug Administration (FDA) determined that specific naloxone products, including Narcan, which can reverse the effects of opioids, typically in instances of an overdose, are safe enough to potentially be sold over the cou
Calls To Poison Control Centers On The Rise In This State Due To Delta-8 Products
Virginia's poison control centers recently revealed how often they deal with calls related to synthetic cannabis products.
GOP Rep. Seeks Protection For Vets Who Use Medical Marijuana: They Shouldn't Lose Their Benefits
A new bill sponsored by Rep.
House Committee Chair To Question FDA Head On Hemp-Derived CBD, Medical Devices
Congressman James Comer plans to investigate the U.S. Food and Drug Administration (FDA), according to the U.S.
Jazz Pharmaceuticals Files Patent Infringement Against Generic Drugmakers In New Jersey's District Court
Jazz Pharmaceuticals (NASDAQ: JAZZ), a drug company behind the CBD-based medication Epidiolex, recently filed a lawsuit against Teva Pharmaceutical Industries Ltd (NYS
Bipartisan Cannabis Research Bill Could Cause 'Dire Unintended Consequences' For Industry, Reform Groups Say
Recently, the Global Alliance for Cannabis Commerce (GACC) and Law Enforcement Action Partnership (LEAP) sent a letter to Senate Majority Leader Chuck Schumer (D-NY) expressing their support for streamlining can
Bipartisan Lawmakers Call Out FDA's 'Inadequate' Response To Hemp And CBD Regulations
Bipartisan House members sent a letter to the FDA commissioner to complain about the agency's “completely insufficient response” to their bill, which called for hemp-derived CBD to be permitted and regulated as a food additive. 
The U.S. Court Of Appeals Says No To Removing Marijuana From Schedule 1— Says That's Up To Congress
The United States Court of Appeals for the Second Circuit ruled that the federal government’s decision to classify cannabis as a Schedule I controlled substance (without any accepted medical utility) is arguably “irrational,” but it is not unconstitutional.
CBD: New Study Finds Wide Evidence Of Mislabeling For Cannabidiol Products
In a new study, Johns Hopkins Medicine researchers tested more than a hundred topical cannabidiol (CBD) products, that are available online and at retail stores and found "significant evidence of inaccurate and mi
New Restrictions On Synthetic Marijuana: Harm To The Cannabis Industry?
Beginning July 1, the Oregon Liquor and Cannabis Commission (OLCC) will be restricting the sale of some artificially derived synthetic cannabinoids in the state, reported the Oregonian.
Concern About Marijuana Copycat Products Resembling Common Food Brands: State Attorneys General Call On Action To Congress
A bipartisan coalition of 23 state attorneys general sent a letter to Virginia AG Jason Miyares (R) and Nevada AG Aaron Ford (D), demanding action to prevent the sale of packaged marijuana products that resemble popular food
Freshpet Recalls Dog Food Sold At Target And Walmart Over Possible Salmonella Contamination
Freshpet Inc (NASDAQ: FRPT) has recalled one of its dog food products sold at Target Corporation (NYSE: TGT) and Walmart Inc (NYSE:
Kansas Patients Now Have Access To Medicinal Cannabis Without A State Law
On June 2, Governor Laura Kelly (D) signed new legislation that would allow Kansans to obtain prescription drugs derived from cannabis-related products.
Bette Midler Panned For Breastfeeding Remark In Wake Of Baby Formula Shortage
Singer and actress Bette Midler received a round of boos on Twitter Inc (NYSE: TWTR) after volunteering the idea that American women impacted by the ongoing baby formula shortage turn to breastfeeding.
FDA Investigating Reported Illnesses Tied To Lucky Charms Cereal
Scores of consumers weren’t feeling very lucky after eating General Mills’ (NYSE: GIS) Lucky Charms cereal, with multiple reports of illness occurring after having a bowl of the longtime breakfast staple.
Stock Wars: Axsome Therapeutics Vs. Global Blood Therapeutics
Benzinga’s weekly Stock Wars matches up two leaders in a major industry sector with the goal of determining which company is the better investment.